|
⚲
|
| Juvaris Bio Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001347758 |
| Sale | 2009-09-11 ($25.1 M Offered, $15.1 M Sold) |
| Fund | |
| Phone | 6506978828 |
| Address | 866 Malcolm Road, Suite 100 Burlingame, 94010 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2009-09-24 (D) |
| Exemption | 506 |
| Remaining | $10,013,753 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Kimberlee Gonzaga | Executive Officer | |
| Michael Ross | Director | |
| Thomas Monath | Director | |
| Grant Pickering | Executive Officer | |
| Lewis Williams | Director | |
| Carol Brosgart | Director |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
RCS - Mezzco GCO LLC
✚
|
0.0 | |
|
Primiano Christopher Brett
✚
|
0.0 | |
|
Prins H LLC
✚
|
0.0 | |
|
Private Credit Managers IV LLC
✚
|
0.0 | |
|
Private Credit Managers IV Offshore LP
✚
|
0.0 | |
|
Private Credit Portfolio 2022 LP
✚
|
0.0 | |
|
Private Credit Portfolio GF 2022 LP
✚
|
0.0 | |
|
Private Credit Portfolio TE 2022 LP
✚
|
0.0 | |
|
Private Diversifiers Portfolio 2022 LP
✚
|
0.0 | |
|
RCS - AMP Holdings LLC
✚
|
0.0 |